Based on the multiple forms of physical and biological containment proposed by AquaBounty Technologies in the original application and subsequent supplement, the FDA found that an approval of the application and supplemental application related to AquAdvantage Salmon would not cause a significant impact on the environment of the United States. The science behind the salmon involved the introduction of a growth hormone gene from Chinook salmon into the genome of Atlantic salmon. Required fields are marked *. It is possible that consumers will eat GM salmon in cafeterias and restaurants if they are not told. It does so because it contains an rDNA construct that is composed of the growth hormone gene from Chinook salmon under the control of a promoter (a sequence of DNA that turns on the expression of a gene) from another type of fish called an ocean pout. The company could break ground in early 2021. // //